Clinical Development and Regulatory Approval Risks: The success of Roche's future growth relies on its ability to discover, develop, and obtain regulatory approval for new pharmaceutical and diagnostic products. Failures in clinical trials or delays in regulatory submissions can significantly impact the pipeline and future revenue.

Patent Expiry and Biosimilar/Generic Competition Risks: Key pharmaceutical products facing patent expiration are exposed to competition from lower-priced biosimilars and generic versions. This erosion of market share can lead to substantial revenue declines for established blockbusters.

Pricing Pressure and Healthcare Policy Risks: Global healthcare systems are under increasing pressure to contain costs, leading to demands for lower drug prices and more stringent reimbursement policies. Government reforms and payer negotiations can negatively impact profitability and market access for Roche's products.